Orexin and melanin-concentrating hormone (MCH) have been implicated in mediating a variety of different behaviors. These include sleep and wakefulness, locomotion, ingestive behaviors, and fight-or-flight response, as well as anxiety-and panic-like behaviors in rodents. Despite such diversity, all these processes require coordinated recruitment of the autonomic and somatomotor efferents. We have previously mapped the locations of presympathetic-premotor neurons (PSPMNs) in the rat brain. These putative dual-function neurons send trans-synaptic projections to somatomotor and sympathetic targets and likely participate in somatomotor-sympathetic integration. A significant portion of these neurons is found within the dorsomedial (DMH) and lateral hypothalamus (LH), areas of the brain that contain MCH-and orexin-synthesizing neurons in the central nervous system. Thus, we hypothesized that hypothalamic PSPMNs utilize MCH or orexin as their neurotransmitter. To test this hypothesis, we identified PSPMNs by using recombinant strains of the pseudorabies virus (PRV) for trans-synaptic tract tracing. PRV-152, a strain that expresses enhanced green fluorescent protein, was injected into sympathectomized gastrocnemius muscle, whereas PRV-BaBlu, which expresses ␤-galactosidase, was injected into the adrenal gland in the same animals. By using immunofluorescent methods, we determined whether co-infected neurons express MCH or orexin. Our findings demonstrate that PSPMNs synthesizing either MCH or orexin are present within LH, where they form two separate populations. PSPMNs located around the fornix express orexin, whereas those located around the cerebral peduncle are more likely to express MCH. These two clusters of PSPMNs within LH likely play distinct functional roles in autonomic homeostasis and stress coping mechanisms. J. Comp. Neurol. 505:586 -601, 2007.
Orexins (orexin-A and orexin-B; also known as hypocretin 1 and hypocretin 2, respectively) were initially discovered as ligands for two orphan G-protein-coupled receptors Sakurai et al., 1998) . These peptides are derived from a common precursor molecule, prepro-orexin, which is cleaved to form orexin-A (33 amino acids long) and orexin-B (28 amino acids) Willie et al., 2001) . In their initial report described the structure of these peptides and demonstrated that they stimulate short-term food intake. Subsequent investigations have confirmed that these peptides stimulate arousal and feeding behavior in rats and mice (Edwards et al., 1999; Haynes et al., 2000 Haynes et al., , 2002 and have also implicated them in the regulation of emotion, energy homeostasis, reward, and drug addiction (Yamanaka et al., 2003; Akiyama et al., 2004; Boutrel et al., 2005; Harris et al., 2005; Narita et al., 2006; Sakurai, 2007) . It has also been demonstrated that the orexins participate in regulating locomotor activity as part of motivated behaviors, such as foraging for food following fasting (Yamanaka et al., 2003) and that they are part of an integrated cardiovascular and locomotor response to acute stress (Zhang et al., 2006) . In addition, intracerebroventricular administration of orexin-A leads to increases in mean arterial pressure and heart rate in awake behaving rats (Samson et al., 2007) .
Orexin-synthesizing neurons in the central nervous system are found exclusively within the lateral (LH) and dorsomedial (DMH) hypothalamic nuclei Swanson et al., 2005) . Within these regions, orexinsynthesizing neurons are intermingled with those neurons that synthesize melanin-concentrating hormone (MCH). Although these two populations of hypothalamic neurons are located within the same areas, they are neurochemically distinct, as MCH-positive cells do not synthesize orexins and vice versa (Bayer et al., 2002; Swanson et al., 2005) .
MCH is also located in the lateral hypothalamus and is a 19-amino-acid-long neuroactive peptide that is derived from the precursor prepro-MCH (Bittencourt et al., 1992) . MCH was originally discovered in fish but has subsequently been identified in mammals, in whom it is thought to regulate energy balance (Pissios et al., 2006) . In addition to energy balance, MCH neurotransmission has also been implicated in regulating locomotor activity (Marsh et al., 2002; Segal-Lieberman et al., 2003) , and inactivation of the MCH receptor 1 leads to increased wheel running (Zhou et al., 2005) . MCH neurotransmission is also thought to play a role in mediating anxiety-and depression-like behaviors in rodents (Borowsky et al., 2002) . Furthermore, intracerebroventricular infusions of MCH increase rapid eye movement sleep (Verret et al., 2003) and produce bradycardic and hypotensive responses in rats (Messina and Overton, 2007) , suggesting that MCH neurotransmission also participates in regulation of the autonomic nervous system and the sleep/wake cycle.
Taken together, these data suggest that orexins and MCH participate in coordinating activities of somatomotor and autonomic systems and that they do so within the context of motivated behaviors. We have previously used a virally mediated trans-synaptic tract-tracing approach to map the locations of neurons that send polysynaptic projections to skeletal muscle and to the adrenal gland (Kerman et al., 2003 (Kerman et al., , 2006a . We have proposed that these neurons (referred to here as presympathetic-premotor neurons [PSPMNs] ) have dual functions in regulating activities of the sympathetic and somatomotor systems. Although PSPMNs are widely distributed throughout the brain, major clusters of these neurons are found within areas thought to mediate motivated behaviors such as responses to stress (Kerman et al., 2003 (Kerman et al., , 2006a . Such areas include LH and DMH, both regions that have been implicated in mediating stress responses as well as regulating food intake (Kerman et al., 2006a) . These areas also contain all the orexin-synthesizing neurons and the majority of MCH-synthesizing neurons in the central nervous system (Bittencourt et al., 1992; Sakurai et al., 1998) .
Thus, given the proposed role of PSPMNs in regulating physiological aspects of motivated behaviors and the known role of orexins and MCH in coordinating somatomotor and autonomic functions, we hypothesized that a subset of hypothalamic PSPMNs synthesize orexins or MCH. To test this hypothesis we identified PSPMNs by using our previously developed retrograde trans-synaptic tract-tracing paradigm and then used triple-label immunofluorescence to determine whether these cells synthesize orexins or MCH.
MATERIALS AND METHODS
All the procedures regarding animal use in this study conformed to the Guide for the Care and Use of Laboratory Animals of the NIH and were approved by the University of Michigan's University Committee on Use and Care of Animals.
Antibody specificity and distribution of MCH-and orexin-synthesizing neurons
In our initial experiments we sought to compare the distribution of MCH-and orexin-synthesizing neurons in the rat brain. Adult male Sprague-Dawley rats (n ϭ 2; Charles River, Wilmington, MA) were used in these studies. Animals were deeply anesthetized with 1 ml i.p. of 50 mg/ml pentobarbital sodium solution and transcardially perfused with 100 -150 ml of physiological saline followed by 400 -500 ml of a 4% paraformaldehyde solution containing 1.4% l-lysine and 0.2% sodium meta-periodate (PLP) (McLean and Nakane, 1974) . Brains were then extracted, postfixed in PLP overnight, and immersed in 20% sucrose until they sank to the bottom of the container. Tissue was then sectioned coronally on a freezing microtome at a thickness of 40 m and collected into six adjacent bins. Tissue was then stored at Ϫ20°C in cryoprotectant (30% sucrose, 30% ethylene glycol, 1% polyvinyl-pyrrolidine ) until immunohistochemical processing was conducted.
To study the distribution of MCH-positive neurons, we used rabbit anti-MCH serum (Phoenix Pharmaceuticals, Burlingame, CA, cat. #: H-070-47, lot #: 00606). This antibody was raised against full-length peptide (sequence: Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-ValTyr-Arg-Pro-Cys-Trp-Gln-Val) and has been shown to have 100% cross-reactivity against MCH and 0% crossreactivity against orexins, agouti-related peptide, leptin, ␣-melanocyte-stimulating hormone, and neuropeptide Y (manufacturer's technical information).
To prevent nonspecific binding, tissue was first soaked in blocking solution that consisted of 0.3% Triton X-100 (TX-100), 1% normal goat serum (NGS), and 1% bovine serum albumin (BSA) in 0.1 M phosphate buffer (PB; pH 7.4). The antibody was then dissolved in the same blocking mix and reacted with tissue at 1:10,000 or 1:15,000 for 1 hour at room temperature followed by 48 hours at 4°C. The tissue was then reacted with biotinylated goat antirabbit IgG (Vector, Burlingame, CA) at 1:200 in blocking solution for 2 hours at room temperature. Following a brief rinse in 0.1 M PB, the tissue was then reacted with the VectaStain ABC System (Vector), with A and B reagents dissolved at 1:200 each in blocking solution. The reaction was then visualized with 0.04% diaminobenzedine (DAB) as chromogen and 2 ϫ 10 Ϫ5 % H 2 O 2 in 0.1 M sodium acetate.
To verify the specificity of this antibody further, we performed a blocking study in which adjacent sections were incubated with the rabbit anti-MCH serum (as described above) and with rabbit anti-MCH serum preincu-bated with 50 M of the MCH peptide (Phoenix Pharmaceuticals, cat. #: 070-47, lot #: 424859).
To study the distribution of orexin-synthesizing neurons, we used an antibody raised against orexin-A. We used rabbit polyclonal antibody (Abcam, Cambridge, MA, cat. #: ab6214, lot #: 38610), which was raised against a synthetic peptide (sequence: Cys-Arg-Leu-Tyr-Glu-LeuLeu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-ThrLeu), corresponding to amino acids 14 -33 of cow orexin-A, and conjugated to Lys-Leu-His by a glutaraldehyde linker (manufacturer's technical information). This peptide has 100% amino acid identity with rat orexin-A, and it contains three regions of identity with orexin-B for a total of 13 identical amino acid residues between orexin-A and orexin-B . This antibody has been extensively tested to show that it cross-reacts to detect both orexin-A and orexin-B and that it only stains orexinsynthesizing neurons (Nambu et al., 1999) . Tissue was incubated with this antibody diluted to 1:5,000 and then processed and visualized as described above.
Overview of tract-tracing studies
Male Sprague-Dawley rats (n ϭ 11; Charles River) were used in tract-tracing studies. In these experiments we employed transgenic recombinants of an attenuated pseudorabies virus (PRV) strain, PRV-Bartha, for transneuronal tracing of multisynaptic pathways innervating adrenal gland and gastrocnemius muscle. PRV has preferential tropism for axonal terminals (Vahlne et al., 1978 (Vahlne et al., , 1980 . It is transported in the retrograde direction from the terminals to the cell body where the viral genome is replicated in the nucleus (Enquist et al., 1998) . Capsids are assembled and filled with viral DNA in the nucleus, acquire the mature envelope from a late Golgi compartment, and are transported to sites of afferent synaptic contact, where cell-to-cell retrograde transneuronal transmission of infection occurs (Card et al., 1993; Enquist et al., 1998) . The two viral recombinants that we employed were PRV-152 and PRV-BaBlu. Both are derived from PRV-Bartha, which is an attenuated form of the parental strain, PRV-Becker. PRV-BaBlu contains the lac Z gene at the gG locus and produces ␤-galactosidase (␤-gal) under the control of the viral gG promoter (Kim et al., 1999) . PRV-152 carries the gene coding for enhanced green fluorescent protein (eGFP) at the gG locus, which is constitutively expressed under control of the cytomegalovirus immediate early promoter (Smith et al., 2000) . Previous studies have demonstrated that PRV-152 and PRV-BaBlu are transported transsynaptically in a retrograde manner, similarly to PRV-Bartha and that the two recombinants are capable of simultaneously co-infecting the same neuronal population (Standish et al., 1995; Billig et al., 1999 Billig et al., , 2000 Billig et al., , 2001 Smith et al., 2000; Kerman et al., 2003 Kerman et al., , 2006a .
We previously reported a robust negative correlation between the animal's weight and efficiency of infection of gastrocnemius motoneurons, with the largest rate of motoneuron infection in rats of intermediate size that weigh approximately 200 g (Kerman et al., 2003) . Thus, animals in the current study were selected to weigh between 163 and 254 g for an average of 197 Ϯ 8 g (mean Ϯ SEM). Animals were anesthetized with either an inhalable or an injectable anesthetic protocol. In the former case anesthesia was induced with 5% isoflurane vaporized in 1-1.5 L/min of O 2 and maintained with a 1.5-2.5% concentration. Alternatively, animals were injected i.p. with a mix of ketamine and xylazine (60 mg/kg ketamine and 7 mg/kg xylazine). Once a surgical plane of anesthesia was achieved such that there was no spontaneous movement and there were no withdrawal responses to tail and/or foot pinch, hindlimb sympathectomy was performed.
In addition to somatic motor efferents, the hindlimb is also innervated by sympathetic efferents that project to blood vessels, sweat glands, and other smooth muscle targets (Jä nig and McLachlan, 1992) . To prevent infection of sympathetic pathways following injection of PRV-152 into the gastrocnemius muscle, the hindlimb was surgically sympathectomized in all animals by using a previously described approach (Kerman et al., 2003) . Briefly, the lumbar sympathetic nerve was dissected via a ventral laparotomy and was extirpated from the level of the renal artery caudal to the bifurcation of the abdominal aorta. Neural plexuses running along the descending aorta and inferior vena cava were also stripped off under microscopic observation by using fine forceps. The abdominal aorta and the inferior vena cava were then swabbed with 10 -20% phenol dissolved in ethylene glycol. The abdominal musculature was closed with sutures, and the overlying skin was closed with surgical staples. This procedure is effective at removing the large majority of sympathetic efferents to the hindlimb, as evidenced by the lack of infection in the intermediolateral cell column in the same animals that exhibited robust infections of lumbar motoneurons (Kerman et al., 2003 (Kerman et al., , 2006a .
Following sympathectomy and a 2-10-day recovery period, the animals were reanesthetized and injected with PRV-152 into either their right (n ϭ 2) or left (n ϭ 9) gastrocnemius muscle. Following a 24 -32-hour recovery period, the same rats were reanesthetized and were injected with PRV-BaBlu into their left adrenal glands. Choice of anesthetic regime had no effect on viral infection or transport.
At the conclusion of the survival period following transport of viral tracers, animals were deeply anesthetized with 1 ml i.p. of 50 mg/ml pentobarbital sodium solution and transcardially perfused with 100 -150 ml of physiological saline followed by 400 -500 ml of a 4% paraformaldehyde solution containing 1.4% l-lysine and 0.2% sodium meta-periodate (PLP) (McLean and Nakane, 1974) .
Double-virus injections
Viral recombinants used in the present studies were harvested from pig kidney cell cultures at a titer of 10 8 to 10 9 pfu/ml. Viral stocks were aliquoted in 50-l volumes and stored at Ϫ80°C. At the times of injection viral aliquots were removed from the freezer and kept on ice until immediately before injections.
To determine the location of neurons coordinating muscle contraction and autonomic activity, rats received injections of PRV-152 into their gastrocnemius muscles and injections of PRV-BaBlu into their adrenal glands. In each animal the gastrocnemius muscle was injected with 30 l of PRV-152, which was divided into multiple injections of 1.0 l. The adrenal gland was dissected via a left flank incision and gently separated from surrounding viscera and fat; the adjacent connective tissue was then retracted to facilitate access to the gland. Two or three injections of PRV-BaBlu were then made into the gland through a glass pipette attached to a 10-l Hamilton syringe; the total volume of virus injected was 2-4 l. Following each injection the gland was swabbed with a cotton-tip applicator to decrease nonspecific viral spread. We previously demonstrated that this injection protocol produces an efficient infection of target neurons and does not result in spread of virus to non-target tissues (Kerman et al., 2003) .
Injected animals were assigned to one of three groups: short, intermediate, and long survival times. In the short survival group (n ϭ 3) rats survived for 121-122 hours following injection with PRV-152 and for 96 -97 hours following PRV-BaBlu injection. We chose this survival time point because this is the earliest time point at which appreciable numbers of double-infected neurons are detected in the rat hypothalamus (Kerman et al., 2006a) . Because a single replication cycle of the virus is 10 -12 hours (Demmin et al., 2001) , we therefore decided to extend the survival times by 10 -12 hours to determine the maximal number of double-infected neurons that express MCH and orexins. Accordingly, in the intermediate survival group (n ϭ 4) the animals survived for 132 or 136 and 108 or 112 hours following injections with PRV-152 and PRV-BaBlu, respectively. In the late survival group (n ϭ 4) the animals survived for 143-144 and 111-120 hours following injections with PRV-152 and PRV-BaBlu, respectively.
Tissue processing
Following transcardial perfusion with PLP (see above), the entire brain was extracted and postfixed in PLP overnight. Brains were then immersed in 20% sucrose until they sank to the bottom of the container; they were sectioned coronally on a freezing microtome at a thickness of 35 or 40 m and collected into six bins. Tissue was stored at Ϫ20°C in cryoprotectant until immunohistochemical processing was conducted.
For immunofluorescent detection in the brain, tissue was initially rinsed with 0.1 M PB several times at room temperature. It was then incubated for 1 hour in the blocking solution (1% NGS, 1% BSA, and 0.3% TX-100 in 0.1 M PB). Sections were then reacted with a cocktail of primary antibodies-chicken anti-GFP IgY (Abcam, product # 13970) at 1:2,000, mouse anti-␤-gal IgG (Sigma, St. Louis, MO, product # G4644) at 1:1,000, and either rabbit anti-MCH at 1:10,000 or rabbit anti-orexin at 1:500 -diluted in the above blocking solution. In each animal adjacent tissue bins were processed for orexin, GFP, ␤-gal triple-labeling and for MCH, GFP, ␤-gal triple-labeling. The chicken anti-GFP antibody was raised against recombinant full-length protein. This antibody yields a single band on Western blot and detects GFP in transgenic mice expressing GFP in lamina II of the spinal cord (manufacturer's technical information). We have previously determined absence of staining with this antibody in uninfected rat tissue sections (Kerman et al., 2006b) . Mouse anti-␤-gal antibody was developed in mouse peritoneal cavities by using ␤-gal purified from E. coli as the immunogen. Using Western blot, this antibody was shown to be specific for ␤-gal in its native form (116 kDa), and it reacts only with ␤-gal from E. coli (manufacturer's technical information). The specificity of this antibody in immunofluorescent experiments has been previously documented (Kerman et al., 2003) .
Following 48-hour incubation at 4°C in the primary antibody solution, the tissue was rinsed several times with 0.1 M PB and then reacted with a secondary antibody solution, which consisted of donkey anti-mouse IgG con- 
Tissue analysis
Images of antibody-labeled MCH and orexinsynthesizing neurons were taken at 10ϫ magnification with a flat-field correction by using a Zeiss Axiophot upright light microscope (Carl Zeiss MicroImaging, Thornwood, NY), operated by a Ludl motorized stage that was connected to a Ludl MAC2000 XYZ controller module (Ludl Electronic Products, Hawthorne, NY). Images of individual fields of view were stitched together by using the virtual slice tool in Stereo Investigator software (MicroBrightField, Williston, VT) on a Dell PC.
Immunofluorescently labeled tissue was examined by using a Leica DMR photomicroscope (Wetzlar, Germany) and with an Olympus FluoView 1000 laser scanning confocal microscope (http://www.olympusfluoview.com/). Swanson's (2004) rat atlas was used as a reference for anatomical classification. When using Leica DMR microscope, the presence of each fluorophore was detected by using specific filter sets (Chroma Technology, Brattleboro, VT) with the following respective excitation and emission ranges: Alexa Fluor 488, 440 -520 nm and 500 -555 nm (green fluorescence); CY3, 535-560 nm and 545-625 nm (red fluorescence); and Alexa Fluor 647, 560 -680 nm and 625-775 nm (far red fluorescence).
Adjacent black-and-white images of the LH were digitized under a 20ϫ objective; images were then stitched together by using the Photomerge function in Adobe Photoshop CS (Adobe Systems, San Jose, CA). Each of these large stitched images corresponded to a different fluorescent filter set and was pseudocolored as follows: GFPpositive neurons, green; ␤-gal-containing cells, red; and MCH-or orexin-positive neurons, blue or cyan. These pseudocolored images were then overlaid, and colocalization of two or three fluorophores was determined by turning each layer on and off to determine location and color of each cell. Brightness and contrast of images were optimized for presentation purposes, and figures were prepared in Photoshop.
Statistical analyses
Potential differences in distribution of labeled neurons between perifornical and peripeduncular regions were evaluated with repeated measures ANOVA with region (perifornical vs. peripeduncular) and anatomical level as independent variables and percentage of cells that were either MCH-positive PSPMNs or orexin-positive PSPMNs as a dependent variable. Statistical analyses were carried out in StatView 5.0 (SAS Institute, Cary, NC), and significance was set as P Ͻ 0.05.
RESULTS

Specificity of the MCH antibody
To confirm the specificity of the MCH antibody, we performed a blocking study with the specific MCH peptide.
In this experiment, sections through the LH were reacted with the anti-MCH antibody with and without preincubation of MCH peptide. Under control conditions we detected robust labeling in LH around the cerebral peduncle (Fig.  1A) . The observed MCH antibody labeling was completely abolished by preincubation with the MCH peptide (Fig.  1B) , thus confirming the specificity of this antibody for MCH.
Distribution of MCH-and orexinsynthesizing neurons
Distribution of MCH-and orexin-synthesizing neurons was studied in sections from adjacent (1 in 6 series) bins that were visualized by using DAB as the chromogen. These studies demonstrated that although MCH-positive neurons were distributed throughout LH, they formed two clear groupings. The first cluster of MCH neurons was located around the fornix (perifornical region), whereas the second cluster of these cells was found around the cerebral peduncle (peripeduncular region). Figure 2A -C demonstrates this distribution pattern of MCH-positive neurons in LH. Note the clustering of neurons in the perifornical and peripeduncular regions, which is especially prominent at the caudal level that we examined ( Fig. 2A) .
Although orexin-positive neurons occupied a similar area within LH, it was apparent that the bulk of these neurons was located more medially than the MCHpositive cells. Figure 2D -F illustrates the distribution of orexin-positive cells; note that these neurons are preferentially distributed within the perifornical region compared with the peripeduncular region. Within the perifornical region, orexin-positive cells also appeared to be more prevalent than the MCH-positive cells (compare the labeling in Fig. 2F with that in Fig. 2C ).
Expression of MCH within PSPMNs
In line with our previous observations (Kerman et al., 2006a) , we detected considerable numbers of doubleinfected neurons within LH and DMH across all three survival groups. Within LH these neurons were equally distributed throughout the nucleus and were as likely to be located in the perifornical region as in the peripeduncular region.
We conducted triple-labeling experiments aimed at determining whether hypothalamic PSPMNs expressed MCH. In these experiments MCH-positive neurons were tagged with a far red fluorophore and were pseudocolored cyan. Cells that send polysynaptic projections to hindlimb muscle were tagged with a green fluorophore, and those that send polysynaptic projections to the adrenal gland were tagged with a red fluorophore. Thus, double-infected neurons appeared yellow, whereas triple-labeled neurons appeared as a mixture of all three colors. Figure 3 illustrates examples of neurons infected with PRV-152 (green), or PRV-BaBlu (red), or both (yellow) and their relationship to the MCH-synthesizing neurons (cyan). We detected MCH within PSPMNs throughout LH; however, these triple-labeled cells appeared to be more numerous within the peripeduncular region (Fig. 3D2 ) than within the perifornical region (Fig. 3D1) .
We then mapped the locations of MCH-positive PSPMNs, as well as the locations of neurons that were infected with only one PRV strain but also expressed MCH. These maps were created at three different rostrocaudal levels of the rat hypothalamus and across the three different survival periods used in the current study. Figure 4 illustrates the distributions of these cells at different survival times. Note that at the earliest survival time there are considerable numbers of PSPMNs in LH and DMH (Fig. 4A) . Some of these neurons express MCH (black circles) and are intermingled with MCH-negative PSPMNs (yellow squares). Furthermore, these neurons are present around the fornix (in the perifornical region) and around the cerebral peduncle (in the peripeduncular region).
With increased survival time, the numbers of detected double-infected neurons increased and these cells were present throughout LH and DMH. However, with these longer survival times MCH-positive PSPMNs (black circles) segregated preferentially toward the peripeduncular region (Fig. 4B,C) .
Expression of orexins within PSPMNs
We conducted triple-labeling experiments to determine whether hypothalamic PSPMNs are orexinergic. In these experiments orexin-positive neurons were tagged with a far red fluorophore and pseudocolored cyan. Neurons that send polysynaptic projections to hindlimb muscle were tagged with a green fluorophore, whereas those sending polysynaptic projections to the adrenal gland were tagged with a red fluorophore. Figure 5 illustrates data from these experiments; note that in these examples the numbers of orexinpositive PSPMNs are greater within the perifornical area (Fig. 5D1 ) compared with the peripeduncular area (Fig. 5D2) .
As with the MCH-positive neurons, we mapped the locations of orexin-positive PSPMNs in relation to the orexin-negative double-infected neurons as well as to orexin-positive single-infected neurons (Fig. 6 ). This mapping revealed that orexin-positive PSPMNs were detected even at the earliest survival time point and that the numbers of double-infected cells increased with longer survival times. Furthermore, as the numbers of PRV-infected neurons increased with increasing survival, orexin-positive (D-F) . Note the clustering of MCH-positive neurons around the fornix and at the medial edge of the cerebral peduncle, which is especially pronounced at the caudalmost level (A). Although orexinergic neurons are distributed throughout the lateral hypothalamus, they tend to cluster in the perifornical region. This is especially prominent at the rostralmost level (F). Abbreviations: 3v, third ventricle; cpd, cerebral peduncle; fx, fornix; mtt, mammillothalamic tract; ot, optic tract. Scale bar ϭ 300 m in D (applies to A-F). 
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PSPMNs preferentially clustered within the perifornical region of LH (Fig. 6B,C) .
Comparison of the distribution of MCH-and orexin-positive PSPMNs
To compare the distribution of MCH-and orexinpositive PSPMNs directly, double-infected neurons that were positive for each of these peptides were mapped onto corresponding atlas plates from Swanson's (2004) rat brain atlas. Figure 7 illustrates data from this mapping study; at each survival time point MCH-and orexin-positive PSPMNs were projected onto the same atlas plate (plate #30 in Swanson's (2004) rat brain atlas. These data demonstrate a clear segregation of MCH-(red dots) and orexin-(blue dots) synthesizing PSPMNs into lateral and medial clusters, respectively. This clustering is apparent at intermediate (Fig. 7B) and long (Fig. 7C ) survival time points.
To determine whether this segregation into medial and lateral groups of orexin-and MCH-positive PSPMNs is true throughout the rostrocaudal extent of LH, we performed the same mapping procedure at three different rostrocaudal levels for data collected from two of the longsurviving animals. Figure 8 illustrates results from this study; these data also indicate segregation of MCH-and orexin-positive PSPMNs into lateral and medial groups within LH.
Quantification
To determine regional differences in the distribution of PRV-infected neurons, we quantified the numbers of: 1) Fig. 4 . Distribution of MCH-and PRV-containing neurons in the hypothalamus. Anatomical landmarks were traced from original sections, and locations of virus-infected cells were plotted onto these maps. Only one hemisection is presented from each level, but the pattern of labeling was symmetrical. Each symbol represents one neuron on the actual section. Yellow squares represent neurons coinfected with PRV-152 (polysynaptic projections to hindlimb muscle) and PRV-BaBlu (polysynaptic projections to adrenal gland). Black circles represent neurons co-infected with PRV-152 and PRV-BaBlu that also express MCH. Red triangles represent MCH-containing neurons that are infected only with PRV-BaBlu, and aqua diamonds indicate MCH-containing neurons infected only with PRV-152. Labeling was examined at three rostrocaudal levels (similar to the ones represented in Figure 2 : 1, caudal; 2, intermediate; 3, rostral. Panels on the left (A1-A3) are from an animal in the short survival group, those in the middle (B1-B3) are from an animal in the intermediate survival group, and those on the right (C1-C3) are from an animal in the long survival group. Note that although double-infected neurons are distributed throughout the lateral and dorsomedial hypothalamus, PSPMNs that express MCH are preferentially distributed in the peripeduncular region (along the medial edge of cerebral peduncle). This is especially prominent at longer survival time points (for example, C2). Abbreviations as in Figure 2 .
The Journal of Comparative Neurology. DOI 10.1002/cne Fig. 5 . Co-localization of viral reporter genes with orexin in neurons of the lateral hypothalamus. Triple-labeled sections were imaged with a laser-scanning confocal microscope taking 40 -60 optical sections per field of view. For each image the z-stack was compressed, and images were rendered for three-dimensional representation. A1,A2: Orexin-positive neurons were tagged with Alexa Fluor 647 and pseudocolored with cyan. B1,B2,C1,C2: Hypothalamic neurons that send polysynaptic projections to hindlimb muscle were infected with pseudorabies virus (PRV)-152, tagged with Alexa Fluor 488, and pseudocolored with green (B1,B2); neurons with polysynaptic projections to the adrenal gland were infected with PRV-BaBlu, tagged with CY3, and pseudocolored with red (C1,C2). D1,D2: Merged images of A1-C2. A1-D1: Images from the perifornical region (note the edge of the fornix outlined with a dashed line). A2-D2: Images from the peripeduncular region. Triple-labeled neurons (orexin-positive PSPMNs) are shown with arrows. Double-infected neurons that are orexin-negative are shown with arrowheads. Thick arrows in A1-D1 and A2-D2 show orexin-positive neurons that were infected only with PRV-BaBlu. Note greater numbers of triple-labeled neurons in the perifornical region (1) compared with the peripeduncular region (2). Images were taken from the same animal as shown in Figure 4 . Abbreviation as in Figure 2 . Each box of the grid is 32 m.
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double-infected neurons that were MCH-or orexin-negative; 2) double-infected neurons that were MCH-or orexinpositive; and 3) neurons that were infected with only one of the PRV strains and were either MCH-or orexinpositive. This procedure was carried out in tissue obtained from three rats from the intermediate survival time point. This survival time was chosen because it is the first time point at which appreciable numbers of double-infected neurons are detected that probably send direct projections to the spinal cord. Quantification was performed on sections from three different anatomical levels, as illustrated in Figure 2 .
Digitized tissue sections were marked up with different symbols representing these combinations of markers (see Figs. 4 and 6 for examples). These maps were then projected onto digital plates from the Swanson's (2004) rat atlas, and symbols were counted within the different hypothalamic nuclei (Tables 1, 2) . Based on Swanson's atlas, the following LH subnuclei were grouped together to represent the peripeduncular region: dorsal region; ventral region, lateral zone; ventral region, medial zone; magnocellular nucleus; and parvicellular region. In addition, the preparasubthalamic nucleus was also included in the peripeduncular region. For the perifornical region, the posterior hypothalamus was included as well as the following LH subnuclei: juxtadorsomedial; suprafornical; juxtaventromedial region, dorsal zone; and juxtaventromedial region, ventral zone.
To evaluate potential differences in the distribution of MCH-positive PSPMNs between perifornical and peripeduncular regions, cell counts for each anatomical level in each animal were expressed as percentage of total neu- rons that were detected (these included MCH-positive PSPMNs, MCH-negative PSPMNs, and neurons that were infected with only one of the PRV strains and expressed MCH). Figure 9A illustrates these data. Potential differences in the distribution of MCH-positive PSPMNs between perifornical and peripeduncular subdivisions were evaluated with repeated measures ANOVA with region (peripeduncular vs. perifornical) and anatomical level as independent variables and percentage of cells as a dependent variable. The ANOVA revealed significant differences in distribution of cells by region (F ϭ 23.390, df 1, 8, P Ͻ 0.01), and no effects of level (P Ͼ 0.1) or level by region interaction (P Ͼ 0.1).
To evaluate potential differences in the distribution of orexin-positive PSPMNs between perifornical and peripeduncular regions, cell counts for each anatomical level in each animal were expressed as percentage of total neurons that were detected (these included orexin-positive PSPMNs, orexin-negative PSPMNs, and neurons that were infected with only one of the PRV strains and expressed orexin). Figure 9B illustrates these data. Potential differences in the distribution of orexin-positive PSPMNs between perifornical and peripeduncular subdivisions were evaluated with repeated measures ANOVA with region (peripeduncular vs. perifornical) and anatomical level as independent variables and percentage of cells as a dependent variable. The ANOVA revealed significant differences in distribution of cells by region (F ϭ 16.414, df 1, 8, P Ͻ 0.05), and no effects of level (P Ͼ 0.1) or level by region interaction (P Ͼ 0.1).
DISCUSSION
In the current paper we focused our attention on hypothalamic PSPMNs. Neurons with putative dual (sympathetic and somatomotor) functions were identified by injecting distinct PRV recombinants into hindlimb muscle and the adrenal gland. Based on our previous reports on the anatomical distribution of the hypothalamic PSPMNs, we hypothesized that a subset of these neurons would be MCH-or orexin-positive. To test this hypothesis, we carried out triple-labeling experiments in which we combined immunofluorescent detection of viral reporter genes with that of orexins and MCH. Our results demonstrate that dual-infected neurons synthesize both orexins (Figs. 5, 6) and MCH (Figs. 3, 4) . Previous studies have demonstrated that orexin-and MCH-positive neurons constitute separate but intermixed populations (Broberger et al., 1998; Elias et al., 1998; Swanson et al., 2005) ; thus MCH-and orexin-positive PSPMNs comprise separate neuronal pop- Fig. 7 . Spatial segregation of melanin-concentrating hormone (MCH)-(red) and orexin-(blue) positive presympathetic-premotor neurons (PSPMNs). Each dot represents one neuron. Dual-infected neurons that were also MCH-or orexin-positive from adjacent sections were projected onto the same section taken from Swanson's rat brain atlas (plate #30, Swanson, 2000) . A: Data taken from one animal in the short survival group. B: Data from two animals in the intermediate survival group. C: Data from two animals in the long survival group. Note that although there is some intermixing between the two populations, the majority of the two types of neurons are spatially segregated. Melanin-concentrating hormone (MCH)-positive presympathetic-premotor neurons (PSPMNs) are distributed more laterally and closer to the medial edge of the cerebral peduncle, whereas orexin-positive PSPMNs are distributed more medially around the fornix and in the dorsomedial hypothalamus. Abbreviations: ARH, arcuate hypothalamic nucleus; COApm, cortical amygdalar nucleus, posterior part, medial zone; DMHa, dorsomedial hypothalamic nucleus, anterior part; DMHp, dorsomedial hypothalamic nucleus, posterior part; DMHv, dorsomedial hypothalamic nucleus, ventral part; fx, fornix; I, internuclear part, hypothalamic periventricular region; LHA, lateral hypothalamic area; LHAd, lateral hypothalamic area, dorsal region; LHAjd, lateral hypothalamic area, juxtadorsomedial region; LHAjvv, lateral hypothalamic area, juxtaventromedial region, ventral zone; LHAm, lateral hypothalamic area, magnocellular nucleus; LHAs, lateral hypothalamic area, suprafornical region; LHAsfp, lateral hypothalamic area, subfornical region, posterior zone; LHAvl, lateral hypothalamic area, ventral region, lateral zone; LHAvm, lateral hypothalamic area, ventral region, medial zone; MEex, median eminence, external lamina; mtt, mammillothalamic tract; PH, posterior hypothalamic nucleus; PR, perireuniens nucleus; PVi, periventricular hypothalamic nucleus, intermediate part; STN, subthalamic nucleus; TUi, tuberal nucleus, intermediate part; TUl, tuberal nucleus, lateral part; TUsv, tuberal nucleus, subventromedial part; TUte, tuberal nucleus, terete subnucleus; V3h, third ventricle, hypothalamic part; vlt, ventrolateral hypothalamic tract; VMHc, ventromedial hypothalamic nucleus, central part; VMHvl, ventromedial hypothalamic nucleus, ventrolateral part; ZI, zona incerta.
The Journal of Comparative Neurology. DOI 10.1002/cne ulations. Our data are consistent with this interpretation and extend it further by demonstrating that orexin-and MCH-positive PSPMNs are spatially segregated. Accordingly, such orexin-positive neurons are distributed mainly within the perifornical region of LH, whereas MCHpositive PSPMNs are found primarily within its peripeduncular subdivision.
Antibody specificity
For data interpretation it is important to consider first the specificity of the antibodies that were used in the current study. In regard to the antibodies used to detect viral reporter genes, we have previously confirmed their specificities by demonstrating absence of staining in noninfected rat brain tissue (Kerman et al., 2003 (Kerman et al., , 2006a . Furthermore, the orexin antiserum employed in this current study has been extensively characterized by Nambu and co-workers (1999) . As part of their study these authors demonstrated that preincubation of the serum with orexins, but not with neuropeptide Y or angiotensin, abolishes the signal (Nambu et al., 1999) . Furthermore, they demonstrated staining with this antibody in cells transfected with prepro-orexin cDNA but not in the mock transfected cells (Nambu et al., 1999) . Although we did not carry out such controls in our study, the pattern of distribution of orexinergic neurons that we observed in our material (Fig. 2D-F ) was consistent with a previous description using both immunocytochemistry and in situ hybridization Sakurai et al., 1998; Nambu et al., 1999; Swanson et al., 2005 ); thus we can be confident of the specificity of the orexin antiserum used in the present study.
The pattern of labeling that we observed with the MCH antibody used in the current study ( Fig. 2A-C) was likewise similar to the pattern of distribution of this peptide that was previously described (Bittencourt et al., 1992; Elias et al., 1998; Swanson et al., 2005) . We further verified the specificity of this antibody by performing a blocking study (Fig. 1 ) in which the antiserum was preincubated with the MCH peptide. Data from this experiment demonstrated the specificity of this antibody as the staining was completely abolished by the preincubation. Thus, we are also confident of the specificity of the MCH antiserum used in this study.
Connectional considerations
It is likely that at least some of the double-infected neurons that we identified in the present study send direct projections to the spinal cord. The presence of such neurons at the earliest survival time in our study is consistent with this notion. Furthermore, the presence of spinally projecting neurons in LH has also been demonstrated by using retrograde tract tracers (Hosoya, 1980; Haring and Davis, 1983; Kohler et al., 1984; Shiosaka et al., 1985; Porter and Brody, 1986) . Therefore, it seems feasible that such hypothalamospinal neurons collateralize to innervate simultaneously adrenal sympathetic preganglionic neurons and lumbar motoneurons. This hypothesis is supported by anatomical investigations that demonstrated the existence of heavy density of orexinergic fibers in the intermediolateral column of the spinal cord and moderate density of these fibers in the ventral horn (van den Pol, 1999) . The presence of MCH-immunoreactive fibers in the intermediolateral cell column and the lumbar ventral horn of the spinal cord has also been demonstrated (Bittencourt and Elias, 1998) . Nonetheless, definitive demonstration of such collateralized projections directly from LH to the spinal cord requires further investigation.
In addition to the direct projections to the spinal cord, LH also contains neurons with projections to the lower brainstem. Among them are neurons that innervate the ventromedial medulla (Hosoya, 1985) , which is the most likely site of this relay because this area contains the greatest numbers of the caudally located PSPMNs (Kerman et al., 2003 (Kerman et al., , 2006b . Thus, it is likely that at least some of the double-infected neurons that we observed at longer survival times synapse on neurons in the ventromedial medulla, which in turn send descending projections to the spinal cord.
One of the major findings of the present study is the spatial separation of orexin-and MCH-positive PSPMNs. The orexinergic dual-infected neurons were more likely to be distributed medially within LH in the perifornical region, whereas MCH-positive PSPMNs were more likely to be found closer to the medial edge of the cerebral peduncle (see Figs. 7 and 8) . This finding is supported by traditional tract-tracing approaches using retrogradely transported fluorescent dyes to study ascending and descending projections from LH (Bittencourt and Elias, 1998) . Bittencourt and showed that descending MCHpositive neurons were distributed laterally within LH along the medial edge of the cerebral peduncle, whereas the ascending neurons were distributed more medially within the perifornical region (see Fig. 6 of their paper). Cvetkovic and colleagues (2004) have also demonstrated that MCH neurons express neurokinin-3 receptor and cocaine-and amphetamine-regulated transcript (CART). However, a distinct cluster of MCH neurons just medial to the cerebral peduncle does not express these markers (Cvetkovic et al., 2004) . Based on their previous observations that neurokinin-3 receptor-negative MCH neurons send descending projections to the spinal cord, whereas neurokinin-3 receptor-positive neurons send ascending projections (Brischoux et al., 2002) , these authors proposed parcellation of MCH neurons into two categories. According to this scheme, class A neurons are neurokinin-3 receptor-and CART-negative and have descending projections, whereas class B neurons are neurokinin-3 receptor-and CART-positive and have ascending projections (Cvetkovic et al., 2004) . The finding that spinally projecting class A MCH neurons are located just medial to the cerebral peduncle strongly supports our current observation of clustering of MCH-positive PSPMNs in the peripeduncular LH.
Previous studies have also demonstrated that LH neurons sending polysynaptic projections to a variety of autonomically innervated targets synthesize orexins. For example, Geerling and colleagues (2003) demonstrated the presence of orexin double-labeled neurons within LH fol- lowing PRV injections into stellate and celiac sympathetic ganglia, as well as following its injection into the adrenal gland and kidney. Closer examination of their data suggests that such double-labeled neurons tend to cluster more around the fornix than other areas in LH (see Figs. 1 and 2 in Geerling et al., 2003) , which is consistent with our findings. Furthermore, a study by Krout and coworkers (2003) suggests that orexinergic perifornical neurons send collateralized polysynaptic projections to the motor cortex and to the central autonomic network.
Functional considerations
Previous studies (reviewed above) along with the data presented in the current paper suggest the existence of two distinct cell groups within LH-one located more laterally at the medial edge of the cerebral peduncle and one located more medially around the fornix. Although both of these cell groups contain neurons that send descending polysynaptic projections that collateralize to innervate hindlimb muscle and adrenal gland, the perifornical group is made up predominantly of orexinergic neurons, whereas the peripeduncular group is made up primarily of MCH-positive neurons.
Although we cannot directly evaluate the functional role of this separation from the present study, previous anatomical, physiological, and behavioral studies of LH offer some clues on the possible functional roles of these two cell groups. We have previously mapped the locations of PSPMNs throughout the central nervous system (Kerman et al., 2003 (Kerman et al., , 2006a . Their pattern of distribution suggests that one of their possible functions is to coordinate activities of the somatomotor and sympathetic systems in response to stress. For example, a major cluster of such neurons is found within the paraventricular nucleus of the hypothalamus, which is the main neuroendocrine integrator of the stress response (Swanson and Kuypers, 1980; Herman and Cullinan, 1997; Reyes et al., 2003) , as well as within the periaqueductal gray, which mediates motor and autonomic components of the "fight-or-flight" response to stress (Bandler et al., 1991; Keay and Bandler, 2004) .
In animals, stress responses can generally be classified into either "active coping" or "passive coping" (Bandler et al., 2000) . Active coping responses are usually elicited by escapable stressors such as the presence of a rival or a predator, whereas inescapable or uncontrollable stressors, such as deep muscular pain, elicit passive coping responses (Bandler et al., 2000) . Active coping is characterized by increased somatomotor activity that is part of escape or fighting behavior, as well as a hypertensive response (Bandler et al., 2000) . On the other hand, passive coping is characterized by general quiescence and hypotension (Bandler et al., 2000) . Our data, taken together with previous physiological and behavioral studies, suggest that the perifornical orexinergic PSPMNs participate in the expression of the active coping response to stress, whereas the peripeduncular MCH-positive PSPMNs support the passive coping stress response.
The concept that orexin and MCH transmitter systems are involved in mediating stress responses is supported by findings that acute stressors induce Fos expression in orexinergic neurons (Winsky-Sommerer et al., 2004) , whereas intracerebroventricular infusions of MCH increase anxiety-like behavior in mice on the elevated plus maze (Smith et al., 2006) . Furthermore, chemical disinhibition of the perifornical area leads to increased blood pressure and heart rate, which are hallmarks of the fightor-flight response; this effect is attenuated in orexin knockout mice (Kayaba et al., 2003) . Likewise, awake behaving orexin knockout mice exhibit decreased cardiovascular and behavioral responses to acute social stressors (Kayaba et al., 2003) . These data are in agreement with the concept that activity of the perifornical orexinergic PSPMNs participates in the expression of active coping stress responses.
In contrast to orexins, MCH neurotransmission likely plays a role in mediating quiescent or passive stress responses. Support for this notion comes from several lines of investigation. For example, melanin-concentrating hormone 1 receptor-deficient mice are hyperactive in their home-cages across a 24-hour period, suggesting that increased MCH transmission would lead to decreased levels of activity (Marsh et al., 2002) . Furthermore, chronic intracerebroventricular administration of MCH leads to hypotension (Messina and Overton, 2007) , a response that would be expected as part of a reaction to chronic inescapable stress. MCH neurons also express ␥-aminobutyric acid (GABA)ergic characteristics, including synthetic enzymes for GABA synthesis and GABAergic receptors (Harthoorn et al., 2005; Hervieu, 2006) . Finally, chemical stimulation with excitatory amino acid infusions within the peripeduncular portion of LH leads to hypotensive responses (Allen and Cechetto, 1992; Pajolla and de Aguiar Correa, 2004) , whereas similar stimuli in the perifornical region lead to hypertensive responses (Allen and Cechetto, 1992) . These stimulation sites correspond closely to the locations of MCH-positive and orexinergic PSPMNs identified in the present study.
CONCLUSIONS
In the current study we used a virally mediated transsynaptic tract-tracing approach to identify neurons with putative dual somatomotor-sympathetic function. These PSPMNs polysynaptically innervate adrenal gland and hindlimb muscle and likely participate in the expression of responses to stress. Our data indicate that these neurons form two distinct clusters within LH, those that synthesize orexins, which are located medially around the fornix, and those that express MCH, which are located laterally at the medial edge of cerebral peduncle. On the basis of previous studies, we hypothesize that these two groups of neurons are recruited differentially by different stressors. Orexinergic perifornical PSPMNs likely participate in active coping responses and may thus be recruited by escapable stressors, whereas MCH-positive peripeduncular PSPMNs likely participate in passive coping responses and may thus be recruited by inescapable stressors. Future investigations will be required to test this hypothesis.
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